Home LiteratureArticle Details
PMID: 3572301 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Sialophorin, a surface sialoglycoprotein defective in the Wiskott-Aldrich syndrome, is involved in human T lymphocyte proliferation.

The Journal of experimental medicine ·Vol. 165 ·No. 5 ·1987-05-01 ·Pages 1383-92

Mentzer SJ, Remold-O'Donnell E, Crimmins MA, Bierer BE, Rosen FS, Burakoff SJ

Abstract

The mAb L10 was used to determine the distribution and the function of sialophorin, the heavily glycosylated surface molecule that is deficient/defective in lymphocytes of patients with the X-linked immunodeficiency Wiskott-Aldrich syndrome. Dual-parameter FACS analysis indicated that sialophorin is expressed on CD4+ and CD8+ lymphocytes, on a subpopulation of peripheral blood B lymphocytes, on all thymocytes, and on a subpopulation of bone marrow cells. Functional studies demonstrated that L10 mAb stimulates the proliferation of peripheral blood T lymphocytes as measured by stimulation of [3H]thymidine incorporation. The time course and magnitude of increased [3H]thymidine incorporation by T lymphocytes in response to L10 mAb paralleled that induced by anti-CD3 mAb. Effective stimulation was dependent on the presence of monocytes and the Fc portion of L10 mAb. Stimulation of lymphocytes by L10, like stimulation by anti-CD3 mAb, involves increased expression of 4F2, HLA-DR, and IL-2-R. These observations suggest that sialophorin functions in T cell activation.

MeSH Terms
Antibodies, Monoclonal/pharmacology Antigens, CD Humans Leukosialin Lymphocyte Activation/drug effects Lymphocyte Depletion Lymphocytes/immunology Membrane Proteins/deficiency Monocytes/physiology Sialoglycoproteins/metabolism,physiology Tissue Distribution Wiskott-Aldrich Syndrome/blood
Chemicals
Antibodies, Monoclonal Antigens, CD Leukosialin Membrane Proteins SPN protein, human Sialoglycoproteins
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Mentzer S J
Remold-O'Donnell E
Crimmins M A
Bierer B E
Rosen F S
Burakoff S J
References (22)
22 references, click to expand
  1. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.
    N Engl J Med. 1978 Apr 27;298(17):921-7 PMID: 347289
  2. Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes.
    Cell. 1977 Nov;12(3):663-73 PMID: 303545
  3. Identification of a glycophorin-like molecule at the cell surface of rat thymocytes.
    Nature. 1981 Feb 5;289(5797):456-60 PMID: 6970337
  4. Reconstitution of normal megakaryocytopoiesis and immunologic functions in Wiskott-Aldrich syndrome by marrow transplantation following myeloablation and immunosuppression with busulfan and cyclophosphamide.
    Blood. 1981 Apr;57(4):692-6 PMID: 7008865
  5. Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes.
    J Immunol. 1981 Apr;126(4):1409-14 PMID: 7204970
  6. Surface protein abnormalities in lymphocytes and platelets from patients with Wiskott-Aldrich syndrome.
    Lancet. 1981 Dec 19-26;2(8260-61):1387-9 PMID: 6118760
  7. A monoclonal antibody (MMA) that identifies a differentiation antigen on human myelomonocytic cells.
    Clin Immunol Immunopathol. 1982 May;23(2):172-88 PMID: 6179666
  8. Monoclonal antibodies: purification, fragmentation and application to structural and functional studies of class I MHC antigens.
    J Immunol Methods. 1982 Sep 17;53(2):133-73 PMID: 6183363
  9. Bone marrow transplantation in the Wiskott-Aldrich syndrome. Complete hematological and immunological reconstitution.
    Transplantation. 1982 Nov;34(5):284-8 PMID: 6760485
  10. Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol).
    J Clin Invest. 1983 Jul;72(1):171-9 PMID: 6874946
  11. An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein.
    Cell. 1984 Apr;36(4):897-906 PMID: 6231105
  12. Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines.
    J Immunol. 1984 Jun;132(6):3011-8 PMID: 6327814
  13. Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome.
    J Exp Med. 1984 Jun 1;159(6):1705-23 PMID: 6547160
  14. The primary immunodeficiencies. (2).
    N Engl J Med. 1984 Aug 2;311(5):300-10 PMID: 6429535
  15. The large sialoglycoprotein of human lymphocytes. I. Distribution on T and B lineage cells as revealed by a monospecific chicken antibody.
    Eur J Immunol. 1985 May;15(5):417-26 PMID: 3158529
  16. Analysis of the monocyte Fc receptors and antibody-mediated cellular interactions required for the induction of T cell proliferation by anti-T3 antibodies.
    J Immunol. 1985 Jul;135(1):165-71 PMID: 3923099
  17. Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen).
    J Exp Med. 1985 Jun 1;161(6):1513-24 PMID: 3159820
  18. Antibodies to Tp67 and Tp44 augment and sustain proliferative responses of activated T cells.
    J Immunol. 1985 Oct;135(4):2331-6 PMID: 3928743
  19. Purification and chemical composition of gpL115, the human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome.
    J Biol Chem. 1986 Jun 5;261(16):7526-30 PMID: 3711098
  20. Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome.
    Blood. 1986 Dec;68(6):1329-32 PMID: 3779101
  21. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome.
    Lancet. 1968 Dec 28;2(7583):1364-6 PMID: 4177931
  22. Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells.
    J Immunol. 1981 Jan;126(1):359-64 PMID: 7451976
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1987-05-01
Pages
1383-92
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2188304
Subset
IM
Grants
NIAID NIH HHS · AI-21163 · United States
NCI NIH HHS · CA-09280 · United States
NCI NIH HHS · CA-34129 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com